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The complex process of lipolysis mobilizes fatty acids from adipocyte triglyceride stores for energy produc-
tion in muscle and other organs during fasting and exercise. In this issue of Cell Metabolism, Yang, et al.
identify G0S2 as a regulator of the key enzyme, adipose triglyceride lipase.Adipose tissue secures a vast storehouse
of energy. Nutrients providing excess
calories are converted to triglyceride for
storage in lipid droplets of adipocytes.
During fasting and extended exercise,
these triglycerides are hydrolyzed in the
process of lipolysis to release fatty acids
into circulation. The fatty acids are then
taken up by skeletal muscle and other
tissues to fuel energy production.
Triglyceride storage and lipolysis are
controlled by a complex cast of charac-
ters that are maintained in a delicate
balance. The adipose lipases include adi-
pose triglyceride lipase (ATGL), hormone-
sensitive lipase, and monoglyceride
lipase. ATGL cleaves triglycerides, but
not diglycerides or monoglycerides, and
hence is thought to initiate the hydrolysis
of stored lipids (Bezaire et al., 2009;
Schweiger et al., 2006). Hormone-sensi-
tive lipase displays a higher specific
activity against diglycerides than other
neutral lipids; moreover, hormone-sensi-
tive lipase null mice accumulate diglycer-
ides in adipose tissue (Haemmerle et al.,
2002). Thus, diglycerides released during
the initial stage of lipolysis are cleaved
by hormone-sensitive lipase. Monoglyc-
eride lipase catalyzes the final step of
lipolysis, and fatty acids and glycerol are
effluxed from the adipocyte. Lipases,
however, are only part of the story.
Research conducted in the past decade
has revealed that the structural lipid
droplet protein, perilipin, plays a critical
role in controlling the access of lipases
to stored triglycerides (reviewed in Bra-
saemle, 2007). In addition, recent studies
have identified regulatory proteins that
interact with ATGL to activate or attenuate
enzyme activity. CGI-58 (comparative
gene identification-58, also referred to as
alpha/beta hydrolase domain 5 [ABHD5])
serves as a coactivator for ATGL, increas-
ing triglyceride hydrolysis by as much as20-fold in vitro (Lass et al., 2006). New
work in this issue ofCell Metabolism iden-
tifies G0S2 as an inhibitor of ATGL (Yang
et al., 2010).
As triglycerides are synthesized during
feeding, adipocytes reduce lipolysis (by
mechanisms not yet fully understood) to
maximize triglyceride packaging into
lipid droplets. Perilipin coats lipid droplets
and, under fed conditions, limits lipase
access to neutral lipid substrates, thus
reducing lipolysis. During fasting and
while exercising, several signaling cas-
cades trigger lipolysis. In the best-charac-
terized pathway, catecholamines bind to
b-adrenergic receptors on the plasma
membranes of adipocytes, initiating a G
protein-mediated signaling cascade that
elevates cAMP levels and activates
protein kinase A (PKA). Phosphorylation
of perilipin by PKA promotes lipolysis
through several mechanisms. Phosphory-
lation of serine residues within the amino
terminus of perilipin enables the docking
of hormone-sensitive lipase on lipid
droplets via a protein-protein interaction
(Wang et al., 2009); concomitant phos-
phorylation of hormone-sensitive lipase
triggers the translocation of the lipase
from the cytosol to lipid droplets and
increases enzyme activity. In addition,
phosphorylation of carboxy-terminal ser-
ine residues of perilipin is required to
facilitate triglyceride hydrolysis by ATGL
through an as yet unknown mechanism
(Miyoshi et al., 2007).
Liu and colleagues now identify the
protein product of the G0/G1 switch
gene 2 (G0S2) as a modulator of ATGL
activity (Yang et al., 2010). G0S2 was
initially characterized as a transcript
highly expressed during the transition of
blood mononuclear cells between the G0
and G1 phases of the cell cycle. A later
study reported that G0S2 mRNA is most
highly expressed in white and brownCell Metabolismadipose tissue, induced during differenti-
ation of cultured 3T3-L1 and human
SGBS adipocytes, and increased when
adipocytes or hepatocytes are incubated
with ligands for the PPAR family of tran-
scription factors (Zandbergen et al.,
2005). Liu and colleagues have confirmed
some of these findings and provide new
data showing that G0S2 interacts directly
with ATGL to attenuate triglyceride
hydrolase activity (Yang et al., 2010). The
authors study triglyceride hydrolysis
in vitro when ATGL is incubated with
both G0S2 and CGI-58; whereas CGI-58
stimulates triglyceride hydrolysis, the
addition of G0S2 reduces the coactivation
of ATGL by CGI-58. Moreover, addition of
recombinant G0S2 to extracts of both
white and brown adipose tissue attenu-
ates triglyceride hydrolysis in a dose-
dependent manner. Because G0S2 was
shown to have no effect on hormone-
sensitive lipase, the data provide support
for prior observations that ATGL is the
major triglyceride lipase in adipose tissue
(Bezaire et al., 2009; Schweiger et al.,
2006) and add G0S2 as a negative regu-
lator of lipolysis to an increasingly com-
plex model (Figure 1).
Several prior studies have shown that
ATGL is widely expressed in many types
of cells where it is thought to be distrib-
uted both in the cytosol and on lipid
droplets. A recent study has challenged
these observations by showing that
ATGL localizes to a membrane compart-
ment rather than the cytosol and is
recruited to lipid droplets through a
mechanism that requires COPI and COPII
complex proteins (Soni et al., 2009). Liu
and colleagues (Yang et al., 2010) demon-
strate that G0S2 is recruited to lipid
droplets only through direct interaction
with ATGL; knockdown of ATGL elimi-
nates G0S2 localization to lipid droplets.
Moreover, they show that both proteins11, March 3, 2010 ª2010 Elsevier Inc. 173
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Figure 1. Protein Localization during Triglyceride-Storing and Lipolytic Conditions
Under fed conditions, triglycerides are packaged into perilipin-coated lipid droplets. Both ATGL and
hormone-sensitive lipase are sequestered in a nonlipid droplet compartment; ATGL is bound to G0S2.
When b-adrenergic receptors are activated, PKA phosphorylates perilipin, causing dispersion of CGI-
58 and revealing a docking site for PKA-phosphorylated hormone-sensitive lipase. ATGL is recruited to
lipid droplets together with G0S2 in a COP complex-dependent mechanism. Triglyceride hydrolysis is
activated by the association of CGI-58 with ATGL but attenuated by G0S2. Diglyceride is hydrolyzed by
hormone-sensitive lipase (HSL), and monoglyceride is hydrolyzed by monoglyceride lipase (not shown).
Fatty acids (and glycerol) are exported from the adipocyte to fuel energy production in skeletal muscle
and other tissues. Figure reprinted from Figure 7 of Yang et al., 2010.
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Previewstranslocate to lipid droplets following
addition of a b-adrenergic receptor
agonist to 3T3-L1 adipocytes to stimulate
lipolysis. Thus, both ATGL (in a complex
with G0S2) and hormone-sensitive lipase
reside in compartments other than lipid
droplets under triglyceride-storing condi-
tions and are recruited to lipid droplets
when activation of the b-adrenergic sig-
naling pathway signals a need for the
mobilization of lipid stores. This raises
questions as to whether hormone-sensi-
tive lipase is similarly dependent upon
COP complex proteins for transport to
lipid droplets and is part of the same
multiprotein complex. Moreover, the find-
ings suggest the intriguing possibility
that COP-mediated protein trafficking
of lipid droplet-associated proteins may174 Cell Metabolism 11, March 3, 2010 ª201be controlled by hormonal signals in
adipocytes.
Many questions remain for further
investigation. Why is G0S2 required at
the lipid droplet when adipocytesmobilize
lipids? The mechanism by which G0S2
inhibits lipolysis is not yet known; G0S2
may compete with CGI-58 for access to
ATGL and thus attenuate activation of
the enzyme. Alternatively, G0S2 may
block ATGL from gaining access to its
substrate. It is unknown whether G0S2
has an additional function, distinct from
the attenuation of lipolysis. Increased
expression of G0S2 during the G0-to-G1
transition hints that lipolysis may be regu-
lated during the cell cycle, possibly in
diverse cell types. Finally, it is not yet
known how G0S2 and ATGL associate0 Elsevier Inc.with lipid droplets. Does the complex
embed directly into the phospholipid
monolayer covering the triglyceride core
or interact with perilipin or other structural
components of the lipid droplet coat? One
thing is certain: as more components of
the lipolytic pathway are identified, the
mechanism of lipolysis as we understand
it becomes increasingly more complex.REFERENCES
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